Brief: Biocept’S Cnside Assay Identifies Tumor Cells And Actionable Treatment Biomarkers In Patients With Non-Small Cell Lung Cancer
19/08/2021 13:39
Aug 19 (Reuters) - Biocept Inc BIOC.O :
* BIOCEPT’S CNSIDE ASSAY IDENTIFIES TUMOR CELLS AND
ACTIONABLE
TREATMENT BIOMARKERS FROM CEREBROSPINAL FLUID IN PATIENTS WITH
METASTATIC NON-SMALL CELL LUNG CANCER
Source text for Eikon: ID:nBw9M3Sdta
Further company coverage: BIOC.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Biocept
See all newsBrief: Biocept Says Trading Of Common Stock Will Be Suspended By Nasdaq At Opening Of Business On Oct 25
U.S. STOCKS ON THE MOVE-Overstock.com, Biocept, Birkenstock
Biocept slumps after filing for bankruptcy protection
Brief: Biocept CEO Antonino Morales Resigns
U.S. STOCKS ON THE MOVE-Albemarle, Novavax, WeWork